Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Vaccinations01:51

Vaccinations

Overview
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Virulence Phenotypes Differentiate Persistent vs. Resolving Isolates of Human <i>Staphylococcus aureus</i> Bacteremia.

Antibiotics (Basel, Switzerland)·2026
Same author

Editorial for the Special Issue "Staphylococcal Biology and Pathogenesis".

Antibiotics (Basel, Switzerland)·2026
Same author

Prophage-encoded virulence factor, Gp05, contributes to endothelial cell dysfunction and immune evasion to promote persistent methicillin-resistant <i>Staphylococcus aureus</i> endovascular infections.

mBio·2025
Same author

Genetic Correlates of Synergy Mechanisms of Daptomycin Plus Fosfomycin in Daptomycin-Susceptible and -Resistant Methicillin-Resistant <i>Staphylococcus aureus</i> (MRSA).

Microorganisms·2025
Same author

The lack of a biorepository during vaccine trials: A lost opportunity to understand staphylococcal immunity.

Vaccine·2025
Same author

Bicarbonate Within: A Hidden Modulator of Antibiotic Susceptibility.

Antibiotics (Basel, Switzerland)·2025

Related Experiment Video

Updated: May 27, 2026

Development and Assessment of Intracellular Infection Models for Staphylococcus aureus
08:32

Development and Assessment of Intracellular Infection Models for Staphylococcus aureus

Published on: January 17, 2025

Is there a future for a Staphylococcus aureus vaccine?

Richard A Proctor1

  • 1University of Wisconsin, Medical Microbiology/Immunology, 835 Asa Gray, Ann Arbor, MI 48105, United States. rap@facstaff.wisc.edu

Vaccine
|November 26, 2011
PubMed
Summary

Developing a Staphylococcus aureus vaccine requires a shift from antibody-based approaches to cell-mediated immunity. Focusing on the Th17/IL-17 axis may lead to a successful S. aureus vaccine.

Area of Science:

  • Immunology
  • Vaccinology
  • Microbial Pathogenesis

Background:

  • * Previous Staphylococcus aureus vaccine development efforts have been unsuccessful.
  • * Current strategies primarily focus on opsonic antibodies, which have proven insufficient for protection.
  • * Emerging evidence highlights the critical role of cell-mediated immunity in combating S. aureus infections.

Purpose of the Study:

  • * To explore the potential of cell-mediated immunity, specifically the Th17/IL-17 axis, as a novel target for S. aureus vaccine development.
  • * To investigate the mechanisms by which Th17 cells and IL-17 contribute to host defense against S. aureus.
  • * To propose new vaccine strategies based on enhancing Th17/IL-17-mediated immunity.

Main Methods:

  • * Review of existing literature on S. aureus immunity and vaccine development.

More Related Videos

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus (MRSA) Infection
07:32

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus (MRSA) Infection

Published on: September 1, 2023

Related Experiment Videos

Last Updated: May 27, 2026

Development and Assessment of Intracellular Infection Models for Staphylococcus aureus
08:32

Development and Assessment of Intracellular Infection Models for Staphylococcus aureus

Published on: January 17, 2025

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus (MRSA) Infection
07:32

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus (MRSA) Infection

Published on: September 1, 2023

  • * Analysis of the role of Th17 cells and IL-17 in neutrophil mobilization and activation.
  • * Evaluation of the limitations of antibody-dependent immunity against S. aureus.

    • Main Results:

    • * Antibody-based vaccines have consistently failed to provide protection against S. aureus.
    • * The Th17/IL-17 immune axis is crucial for effective host defense against S. aureus.
    • * IL-17 facilitates neutrophil recruitment and activation, essential for controlling staphylococcal infections.

    Conclusions:

    • * A paradigm shift in S. aureus vaccine development is necessary, moving away from solely antibody-centric approaches.
    • * Targeting the Th17/IL-17 pathway offers a promising new avenue for creating an effective S. aureus vaccine.
    • * Future research should focus on strategies to harness and enhance Th17/IL-17-mediated immunity for staphylococcal infection prevention.